Repatha: EPAR - Paediatric investigation plan compliance statement
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Source
European Medicines Agency
Additional Information
medication.label.product_type
pip-compliance
medication.label.permit_number
EMA/690314/2022
medication.label.permit_validity
First published: 2023-01-23T17:00:00Z
Documents
Related Medications
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
Generic Class
AI Voice
Listen to the article content live